The US Bankruptcy Court conditionally approved the amended disclosure statement of GeneLink, Inc. on October 23, 2014. The debtor has filed its first amended disclosure statement in the Court on October 21, 2014. The deadline to vote on the plan will be no later than 7 days before the date of confirmation hearing.

The debtor may file second amended disclosure statement will be by no later than October 31, 2014 and combined disclosure and confirmation hearing will be scheduled for December 3, 2014.